References

  • 1. 07-07617 Tytgat GN Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 67 (9), 1343 - 1357 (2007).
  • 2. 2- U103461-01 27 Jul 2010, Study Number:2002.839 Wang F., Feister Bell H., Thowal S. A double blind, placebo-controlled, randomized, parallel-group pilot study of the efficacy and safety of oral dosis of 20mg Hyoscine butylbromide.
  • 3. P13-08760 Lacy BE, Wang Fm Bowal S, Schaefer EOn-demand Hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain. Scand J Gastroenterol 48 (8), 926 -935 (2013).
  • 4. P11- 06251 Mueller-Lissner S, Schaefer E, Kondla ASymptoms and their interpretation in patients self-treating abdominal cramping and pain with a spasmolytic (butylscopolamine bromide) - a pharmacy-based survey. Pharmacol Pharm 2, 82 - 87 (2011).
  • 5. PDMI Prescription Data 2016
  • 6. P12-12472 Krueger D, Michael K, Allam S, Zeller F, Demir IE, Ceyhan G, Weiser T, Schemann MEffect of Hyoscine butylbromide (Buscopan®) on cholinergic pathways in the human intestine. 20th United Eur Gastroenterology week (UEGW), Amsterdam,20-24 Oct 2012
  • 7. Company Core Data Sheets 0057-06 18 Oct 2010 and 0061-03 11 Aug 2011
  • 8. Most recent IMS Philippines market Data in values, counting units, and share
  • 9. Most recent IMS Growth Potential Study, 2015